Integumentary system Quiz #18, Pharmacotherapy for Bone Disorders  

1. A 68-year-old woman with postmenopausal osteoporosis is started on a medication to increase her bone mineral density. After 6 months of therapy, she reports new onset of jaw discomfort. Which of the following medications is most likely responsible for her symptoms? 

Question 1 of 5

2. A 75-year-old man with a history of chronic kidney disease and secondary hyperparathyroidism is prescribed a medication to lower his parathyroid hormone (PTH) levels. Which of the following drugs is most appropriate for this purpose? 

Question 2 of 5

3. A 58-year-old woman with osteoporosis is started on a new medication that stimulates bone formation. She is informed that this medication is only approved for use for up to 2 years. Which of the following medications is she most likely receiving? 

Question 3 of 5

4. A 65-year-old woman with a recent diagnosis of osteoporosis is concerned about the risk of breast cancer associated with hormone replacement therapy. Which of the following medications could be recommended as an alternative to reduce her risk of vertebral fractures while not increasing her risk of breast cancer? 

Question 4 of 5

5. A patient with osteoporosis is being treated with a monoclonal antibody to reduce his risk of fractures. Which of the following is the mechanism of action of this medication? 

Question 5 of 5


 

¡Por tiempo limitado!

Unete a nuestro boletín mensual y obtén todos nuestros talleres USMLE/ECFMG ¡GRATIS! (+100 videos)

¡Únete a nuestra comunidad de IMGs!

¡Obtén actualizaciones mensuales USMLE y ECFMG, además, obtén un taller USMLE gratis al instante!

"Taller 01: ¿Qué es el USMLE?”

Taller Gratuito USMLE

Este taller proporciona un análisis en profundidad de todos los exámenes USMLE, consejos para tomar exámenes y cómo estudiar de manera efectiva.

OFERTA POR TIEMPO LIMITADO

Especialista ECFMG: Dr. Carla Rebeca Lainez Casal

Facultad de Medicina: Universidad Catholica de Santiago de Guayaquil
ECFMG Certification date: October 13, 2022.
Residency: 2023 Internal Medicine Applicant
+1 7542724970